Logo

NOWDiagnostics Receives CE Mark for its ADEXUSDx COVID-19 Antibody Fingerstick Test

Share this

NOWDiagnostics Receives CE Mark for its ADEXUSDx COVID-19 Antibody Fingerstick Test

Shots:

  • NOWDiagnostics has received a CE mark approval for its ADEXUSDx COVID-19 Ab fingerstick test across 28 countries in the EU. The test first received CE mark for use in moderate/complex laboratory settings on July 28- 2020
  • By measuring the presence of SARS-CoV-2 Abs- the ADEXUSDx COVID-19 Test provides precise and reliable results in 15 min. and eliminates the need for buffers- reagents- or additional equipments
  • ADEXUSDx COVID-19 Test has demonstrated a high level of analytical performance with 95.6% sensitivity and 98.5% specificity and is under FDA’s review for EUA

 ­ Ref: PRNewswire | Image: NOW Diagnostics

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions